NCT02210247View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of Redosing EXPAREL in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

EXPAREL

Trial Locations (1)

45227

Medpace Clinical Pharmacology Unit, Cincinnati

Sponsors
All Listed Sponsors
lead

Pacira Pharmaceuticals, Inc

INDUSTRY